Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways.
雷莫格列净通过激活 AMPK/SIRT1/Nrf2 和抑制 NF-κB 通路发挥对实验性肝纤维化的保护作用
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1586231
ALSuhaymi Naif, Alsugoor Mahdi H, Shokry Aya A, Fayed Hany M, Mohamed Bassim M S A, Afifi Sherif M, Esatbeyoglu Tuba, Korany Reda M S, Elbaset Marawan A